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Effects of Lead on Vascular Reactivity
by Siangshu Chai* and R. Clinton Webb*t
Considerable controversy exists concerning the possible role of lead in the etiology of human
hypertension. In animal studies, there is convincing evidence that lead alters cardiovascular
responsiveness; rats drinking water containing 100 ppm lead develop a chronic, significant 15 to 20
mm Hg elevation in systolic blood pressure. Pressor responsiveness to catecholamines is enhanced in
animals chronically exposed to lead, and the responsiveness of isolated vascular smooth muscle to
adrenergic agonists is increased in rats with lead-induced hypertension. Experimental evidence
suggests that alterations in the cellular mechanisms that regulate intracellular calcium concentration
may contribute to the abnormal vascular function in lead-induced hypertension. Recent work in our
laboratory indicates that increased vascular reactivity in genetic hypertension is associated with
altered activity of the protein kinase C branch ofthe calcium messenger system. Contractile responses
to lead in rabbit mesenteric artery are potentiated by activators (phorbol esters) of this enzyme
complex, and a selective inhibitor of protein kinase C inhibited contractions induced by lead. Based
on these results, it is proposed that a cellular component of the action of lead to increase vascular
reactivity may relate to the role ofprotein kinase C in smooth muscle contraction.
Introduction
Recent evidence indicates that occupational and/or
environmental lead exposure may be related to in-
creased arterial blood pressure (1-3). Furthermore,
studies on experimental animals have demonstrated
that low-level lead exposure produces hypertension
(1,4-10). As most forms of clinical and experimental
hypertension are characterized by increased periph-
eral vascular resistance and abnormal vascular
reactivity (11), it is not surprising that alterations in
the vasculature have been proposed as mechanistic
components ofthe increased blood pressure due to lead
exposure (1-8). This brief review will summarize evi-
dence bearing on the nature of functional vascular
changes in lead-induced hypertension and then cite
evidence suggesting that the effects oflead are related to
altered cellular calcium metabolism. Finally, new ex-
perimental evidence will be presented indicating that
these vascular abnormalities may be due to a specific
action of lead on the protein kinase C branch of the cal-
cium messenger system. Readers interested in a more
complete review of cardiovascular changes that ac-
company lead exposure are referred to other recent
publications (1,12).
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Lead Exposure-and Vascular
Reactivity
Several lines of evidence suggest that increased
vascular reactivity to pressor agents may be one of
several factors that contribute to hypertension (11),.
Animal models of genetic, mineralocorticoid and renal
hypertension, and human essential hypertension are
characterized by abnormal vascular responsiveness to
a number of physiological and nonphysiological
stimuli (10,13,14). The results of different studies are
highly variable, but it is certain that structural and
functional changes in the vascular wall contribute to
abnormal constrictor and dilator responses. Structural
changes that characterize hypertension have been
emphasized by Folkow and co-workers (13), who pre-
sent evidence that the altered geometry of the arterial
vascular wall provides a mechanical advantage to
increase arterial pressure during vasoconstriction.
Structural vascular changes also limit minimal flow
resistance and are primarily an adaptive response to
the elevated blood pressure in the hypertensive state.
The functional vascular changes that characterize
hypertension are varied and complex, but the major
observation is that the activity of the smooth muscle is
enhanced during constrictor events and reduced
during dilator events (11,14).
In rats fed lead, pressor responses to norepinephrine
and angiotensin II have been reported to be eitherCHAJIAND WEBB
increased or unchanged compared to control, un-
treated rats (7,10,15). Because these studies on intact
animals are confronted with the interpretive problem
of differentiating a vascular from a cardiac response,
other investigators have characterized vascular
actions of dietary lead in isolated systems. Webb et al.
(8) observed that helical strips of tail arteries from lead-
treated rats displayed a greater force-generating ability
in response to methoxamine and norepinephrine
than arterial strips from control rats (Fig. 1). This
altered contractile responsiveness to adrenergic
agonists in lead-treated animals was specific, as con-
tractions to depolarizing concentrations of potassium
in arteries from lead-treated rats did not differ from
those in arteries from control rats. The enhanced
contractile responses to methoxamine and norepin-
ephrine were not due to alterations in the activity of
adrenergic nerve endings in the arterial wall, nor
were the responses a function of altered f-adrenergic
activity in the smooth muscle. Furthermore, the
change in maximum force-generating ability was not
an acute alteration, as tail arteries from control rats did
not exhibit abnormal responsiveness to ct-adrenergic
agonists when exposed to lead in the physiological
buffer system.
Studies by other investigators (16-19) have doc-
umented that lead can act in an acute way to alter
vascular reactivity. Prentice and Kopp (16) observed
that rat hearts perfused with 30 ,uM lead had reduced
coronary blood flow compared to untreated hearts,
presumably because lead directly constricted the coro-
nary arteries or interfered with metabolic stimuli that
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FIGURE 1. Concentration-response curve to methoxamine. Helical strips
of tail artery from rats treated with sodium acetate (NaAc) or lead
acetate (PbAc) were made to contract in response to the cumulative
addition of methoxamine to the muscle bath. Arterial strips from
PbAc-treated rats developed more force in response to all
concentrations of methoxamine than did those from control rats.
Values are means ± SEM. The number ofanimals in each group is in
parentheses. Asterisk (*) indicates a statistically significant differ-
ence between rat groups (p < 0.05, unpaired t-test). Reproduced by
permission fromWebb et al. (8).
normally cause vasodilatation. In rabbit aorta, lead
causes contraction when added directly to the muscle
bath (17), and contractile responses to calcium in de-
polarized tail artery segments are augmented by ex-
posure to lead in the buffer system (18,19).
A unique and unusual response that characterizes
vascular reactivity in lead-treated rats was observed by
Webb et al. (8). These investigators observed that tail
artery strips from lead-treated rats exhibited a greater
incidence of spontaneous contractile activity than did
those from control rats. These spontaneous contractions
were only apparent during the equilibration period of
the experiment and were probably due to the leakage of
norepinephrine from nerve endings in the vessel wall.
These functional studies in intact animals and on
isolated vascular preparations indicate that lead alters
the contractile activity of smooth muscle and therefore
may reduce blood vessel caliber, contributing to the
hypertensive state in animals exposed to the heavy
metal.
Calcium and Vascular Effects of
Lead
Because the contractile state of vascular smooth
muscle varies in proportion to the concentration of
calcium in the cytoplasm, several investigators have
tested the hypothesis that increased vascular reactivity
in lead-induced hypertension is due to the ability of
lead to alter cellular calcium metabolism (8,17-19).
Two types of studies have been performed: a) measure-
ment of contractile responses in calcium-free solution
or after treatment with drugs that block membrane
channels for calcium; and b) quantification of the
movement of radiolabeled calcium in blood vessels
treated with lead.
Calcium-free solution attenuates contractile re-
sponses to lead in aortic smooth muscle from rabbits,
suggesting that activator calcium is important for the
effect of the heavy metal (17). Methoxamine-induced
contractions in tail arteries from rats made hyper-
tensive by low lead exposure are less sensitive to the
inhibitory effects of the calcium channel blocker, D-600,
than similar contractions in arteries from nor-
motensive rats (8) (Fig. 2). These results were inter-
preted as indicating that there is an enlarged
intracellular calcium pool in arteries from lead-treated
rats that maintained the contractile effect of meth-
oxamine even in the face of calcium channel blockade.
Supportive evidence for this interpretation was that
tail arteries from lead-treated rats relaxed at a slower
rate after removal of methoxamine from the tissue
bath than control arteries. Presumably, the rate of
relaxation reflected the removal of activator calcium
from the cytoplasm, and this process was abnormal in
arteries from lead-treated rats. (An alternative expla-
nation for these results will be covered in the following
section which deals with the protein kinase C branch
ofthe calcium messenger system.)
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FIGURE 2. D-600 and contraction induced by methoxamine. In the absence of D-600, arterial strips from PbAc-treated rats developed more force
than those from control rats. In the presence of D-600, contractile responses in both groups of rats were depressed, but the absolute magnitude
of depression was similar for both groups (A). Normalization of contractile responses in the presence of D-600 to their respective control
responses indicated that arterial strips from PbAc-treated rats had a smaller component of total contraction that was sensitive to the calcium
channel blocker (B). Values are the mean ± SEM for five rats in each group. Asterisk (*) indicates a statistically significant difference between
rats treated with NaAc and those treated with PbAc (p < 0.05, unpaired t-test). Dagger (t) indicates a statistically significant difference between
the controls and treatment with 10-6 M D-600 within each group of rats (p < 0.05, paired t-test). Reproduced by permission fromWebb et al. (8).
Piccinini et al. (18) observed that in vitro treatment
with lead increased the tissue content of radioactive
calcium in the rat tail artery. Further, the half-time of
the slow component of the radiolabeled calcium
washout (which probably reflects the extrusion of cal-
cium from the cytosol) was attenuated in the presence
of lead. The authors suggested that intracellular cal-
cium binding sites are involved in the action of this
metal in vascular smooth muscle.
Studies on nonvascular tissues also support the
concept that lead interferes with cellular calcium
metabolism (1). This work on vascular and nonvas-
cular tissue is compatible with current works on other
experimental models of hypertension, where it has
been demonstrated that alterations in calcium trans-
port processes may contribute to altered cellular events
leading to elevated arterial pressure (11,14).
Vascular Actions of Lead and
Protein Kinase C Activators
Current concepts about cellular and molecular
events underlying smooth muscle contraction indi-
cate a role for polyphosphoinositide turnover and pro-
tein kinase C activity (20-22). In response to certain
hormones and neurotransmitters, phosphatidylin-
ositol 4,5-bis-phosphate of the plasma membrane is hy-
drolyzed by phospholipase C. One product of this hy-
drolysis, inositol 1,4,5-trisphosphate, has been proposed
to cause a release of calcium from intracellular
membrane stores (21). Another product of receptor-
mediated phosphoinositide metabolism is diacylgly-
cerol, which activates the membrane-bound, calcium
/phospholipid-dependent protein kinase C, resulting
in the phosphorylation of structural and regulatory
proteins involved in contraction (17). Protein kinase
C activators, such as the tumor-promoting phorbol
ester 12-0-tetradecanoylphorbol-13-acetate (TPA), have
been used to study the cellular actions of protein kinase
C in smooth muscle (23-26).
Recent studies in our laboratory have characterized
vascular responsiveness to lead following incubation
with activators and inhibitors of protein kinase C
(Figs. 3 and 4). Isolated strips of rabbit mesenteric
artery contracted in response to the cumulative addi-
tion of lead (10-9-10-5 M) to the muscle bath, and this
contractile effect was potentiated by pretreatment with
0.3 gM TPA (Fig. 3). We propose that an important
action of lead may be to alter the activity of protein
kinase C and therefore modify subsequent cellular
phosphorylation events leading to contraction. Evi-
dence in support of this hypothesis is that contractile
responses to lead were attenuated by the selective
inhibitor of protein kinase C, 1-(5-isoquinolinesul-
fonyl)-2-methylpiperazine (27) (Fig. 4). This inhib-
itor did not alter contractile responses to high concen-
trations of potassium ion, suggesting that the inter-
vention may be selective for protein kinase C-mediated
contraction.
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FIGURE 3. Contractile responses to lead acetate in the presence and
absence ofa phorbol ester. A helical strip ofmesenteric artery from
a rabbit was made to contract in response to lead acetate (10-9 to
10-5 M) before and after treatment with 0.3 pM TPA (added 5 min
before the addition of lead acetate). Contractile responses were
greater in the presence of the phorbol ester than in the untreated,
control condition. The concentrations of lead acetate are noted on
separate scales because force development to lead acetate in the
presence of TPA (- -) was faster than in its absence (-). Repro-
duced by permission from Chai and Webb (unpublished observa-
tions).
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FIGURE 4. Effect ofan inhibitor ofprotein kinase C (H-7) on contractile
responses to lead acetate and potassium chloride. Helical strips of
rabbit mesenteric artery were made to contract in response to lead
acetate (1t7 to i03 M, top tracings) or potassium chloride (6-100
mM, bottom tracings) in the presence (--) or absence (-) of6PiM
H-7. Contractile responses to lead acetate in the presence of the
inhibitor of protein kinase C were greatly attenuated compared to
the control, untreated condition, whereas contractile responses to
depolarizing concentrations of potassium in the presence of the
inhibitor were only slightly depressed compared to the untreated
condition. Reproduced by permission from Chai and Webb
(unpublished observations).
Recent work by Goldstein and co-workers (28) offers
biochemical evidence that lead alters protein kinase C
activity in homogenates of rat brain microvessels.
These investigators assayed for protein kinase C
activity using exogenous lysine-rich histone as a
substrate. Calcium and lead stimulated the activity of
protein kinase C, and lead was more potent than
calcium in increasing the activity of the enzyme. In
addition, it was observed that lead may have a
synergistic action with calcium in the activation of
protein kinase C in cerebral microvessels.
Studies on blood vessels from genetically hyper-
tensive rats have also documented an enhanced con-
tractile response to protein kinase C activators com-
pared to normotensive values (23). As the stimulation
of this enzyme is an important step in membrane
activation by certain hormones and neurotrans-
mitters (20), it is possible that altered protein kinase C
activity contributes to increased vascular reactivity in
hypertension. It appears that a cellular component of
the action of lead in vascular smooth muscle may
relate to the activity ofprotein kinase C.
This work was supported by a grant (HL-27020) from the National
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